Home
Portfolio
Strategy
Team
News
Contact
Investor Login
Home
Portfolio
Strategy
Team
News
Contact
Rallybio Reveals Details of Two Pipeline Programs with the Potential to Transform the Lives of Patients with Rare Diseases
Read Article
News
2021
2020
Archive
February 4, 2021
Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase I Study
February 3, 2021
TMRW Launches World’s First Automated Platform to Safeguard Millions of Frozen Eggs and Embryos Used in IVF
February 3, 2021
Crinetics Pharmaceuticals Advances CRN04777 For Congenital Hyperinsulinism into Phase 1 Study
February 2, 2021
Precision NanoSystems Receives Contribution from the Government of Canada to Build RNA Medicine Biomanufacturing Centre
January 28, 2021
Artiva Biotherapeutics Announces Exclusive Worldwide Collaboration and License Agreement with Merck
January 26, 2021
Orphan Drug Designation Granted to Rezafungin in EU for the Treatment of Invasive Candidiasis
January 25, 2021
Cidara Therapeutics Announces Key Additions to its Board of Directors
January 21, 2021
Steven Tuch Joins Rallybio to Lead Corporate Development
January 20, 2021
Impel NeuroPharma Announces U.S. Food & Drug Administration Acceptance of New Drug Application for INP104 for the Acute Treatment of Migraine
January 19, 2021
Spelman College and IDEAYA Biosciences Announce Partnership for Professional Development of the Next Generation of Female African American Leaders in the Biotechnology Industry
« Previous Page
1
2
3
4
5
…
76
Next Page »
